Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

doi:10.1001/jamainternmed.2018.5142

. 2019 Jan 1;179(1):115-118.

doi: 10.1001/jamainternmed.2018.5142.

Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

Halis K Akturk¹, Daniel D Taylor², Ulas M Camsari³, Amanda Rewers¹, Gregory L Kinney², Viral N Shah¹

Affiliations

¹ Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora.
² School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
³ Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

PMID: 30398521
PMCID: PMC6583413
DOI: 10.1001/jamainternmed.2018.5142

Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

Halis K Akturk et al. JAMA Intern Med. 2019.

. 2019 Jan 1;179(1):115-118.

doi: 10.1001/jamainternmed.2018.5142.

Authors

Halis K Akturk¹, Daniel D Taylor², Ulas M Camsari³, Amanda Rewers¹, Gregory L Kinney², Viral N Shah¹

Affiliations

¹ Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora.
² School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
³ Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

PMID: 30398521
PMCID: PMC6583413
DOI: 10.1001/jamainternmed.2018.5142

Abstract

This survey study investigates whether cannabis use is associated with risk of diabetic ketoacidosis in adults with type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Shah reported receiving research support through the University of Colorado from Sanfo US, Dexcom Inc, Eyenuk Inc, and T1D Exchange clinic registry and consulting fees through the University of Colorado from Sanofi US and Dexcom Inc, all outside the submitted work. No other disclosures were reported.

Cited by

Barriers to Type 1 Diabetes Adherence in Adolescents.
Azar S, Maroun Abou Jaoude N, Kędzia A, Niechciał E. Azar S, et al. J Clin Med. 2024 Sep 24;13(19):5669. doi: 10.3390/jcm13195669. J Clin Med. 2024. PMID: 39407728 Free PMC article. Review.
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005. Diabetes Care. 2024. PMID: 38078584 Review.
Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View.
Padoan F, Colombrino C, Sciorio F, Piacentini G, Gaudino R, Pietrobelli A, Pecoraro L. Padoan F, et al. Children (Basel). 2023 Oct 24;10(11):1721. doi: 10.3390/children10111721. Children (Basel). 2023. PMID: 38002812 Free PMC article. Review.
Unexpected cause of recurrent diabetic ketoacidosis in type 1 diabetes: a case report.
Alduraibi RK, Altowayan YF, AlMharwal BT. Alduraibi RK, et al. BMC Endocr Disord. 2023 Jul 3;23(1):137. doi: 10.1186/s12902-023-01394-3. BMC Endocr Disord. 2023. PMID: 37400799 Free PMC article.
Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA.
Sannegowda R, Villalba K, Suk R, Gurnurkar S, Wasserman RM. Sannegowda R, et al. Curr Diab Rep. 2023 Jan;23(1):1-17. doi: 10.1007/s11892-022-01496-7. Epub 2023 Jan 14. Curr Diab Rep. 2023. PMID: 36640218 Free PMC article. Review.

See all "Cited by" articles

References

1. Hasin DS, Sarvet AL, Cerdá M, et al. . US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017;74(6):579-588. doi:10.1001/jamapsychiatry.2017.0724 - DOI - PMC - PubMed
1. Jadoon KA, Ratcliffe SH, Barrett DA, et al. . Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39(10):1777-1786. doi:10.2337/dc16-0650 - DOI - PubMed
1. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583-589. doi:10.1016/j.amjmed.2013.03.002 - DOI - PubMed
1. Gallo T, Shah VN. An unusual cause of recurrent diabetic ketoacidosis in type 1 diabetes. Am J Med. 2016;129(8):e139-e140. doi:10.1016/j.amjmed.2016.02.033 - DOI - PubMed
1. Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. . An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1-2):137-143. doi:10.1016/j.drugalcdep.2010.02.017 - DOI - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Hasin DS, Sarvet AL, Cerdá M, et al. . US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017;74(6):579-588. doi:10.1001/jamapsychiatry.2017.0724 - DOI - PMC - PubMed

[2] Hasin DS, Sarvet AL, Cerdá M, et al. . US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017;74(6):579-588. doi:10.1001/jamapsychiatry.2017.0724 - DOI - PMC - PubMed

[3] Jadoon KA, Ratcliffe SH, Barrett DA, et al. . Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39(10):1777-1786. doi:10.2337/dc16-0650 - DOI - PubMed

[4] Jadoon KA, Ratcliffe SH, Barrett DA, et al. . Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care. 2016;39(10):1777-1786. doi:10.2337/dc16-0650 - DOI - PubMed

[5] Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583-589. doi:10.1016/j.amjmed.2013.03.002 - DOI - PubMed

[6] Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126(7):583-589. doi:10.1016/j.amjmed.2013.03.002 - DOI - PubMed

[7] Gallo T, Shah VN. An unusual cause of recurrent diabetic ketoacidosis in type 1 diabetes. Am J Med. 2016;129(8):e139-e140. doi:10.1016/j.amjmed.2016.02.033 - DOI - PubMed

[8] Gallo T, Shah VN. An unusual cause of recurrent diabetic ketoacidosis in type 1 diabetes. Am J Med. 2016;129(8):e139-e140. doi:10.1016/j.amjmed.2016.02.033 - DOI - PubMed

[9] Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. . An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1-2):137-143. doi:10.1016/j.drugalcdep.2010.02.017 - DOI - PubMed

[10] Adamson SJ, Kay-Lambkin FJ, Baker AL, et al. . An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1-2):137-143. doi:10.1016/j.drugalcdep.2010.02.017 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

Affiliations

Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical